• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    Cardiovascular Needle Market Research Report- Forecast till 2032 Infographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Cardiovascular Needle Market

    ID: MRFR/MED/0726-HCR
    80 Pages
    Kinjoll Dey
    September 2025

    Cardiovascular Needle Market Trends and Size Analysis By Type (Round-Bodied Needles, Cutting Needles), By Application (Open Heart Surgery, Cardiac Valve Procedures), By Usage (Single Use, Multiple Uses), By End User (Hospitals, Clinics)- Forecast till 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Cardiovascular Needle Market Research Report- Forecast till 2032 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    Cardiovascular Needle Market Summary

    As per Market Research Future Analysis, the Cardiovascular Needle Market was valued at USD 0.08 Billion in 2023 and is projected to grow to USD 0.16 Billion by 2032, with a CAGR of 6.30% from 2024 to 2032. The market is driven by the rising prevalence of cardiovascular diseases, diabetes, and an aging population. The World Health Organization reported that cardiovascular diseases accounted for 31% of global deaths in 2015. Advancements in medical technology and increasing government support in developing countries further fuel market growth. However, the rising adoption of surgical staples may hinder demand for cardiovascular needles. Key players include Becton, Dickinson, and Company, B. Braun Melsungen AG, and Ethicon Inc.

    Key Market Trends & Highlights

    The Cardiovascular Needle Market is witnessing significant growth driven by various factors.

    • Market Size in 2023: USD 0.08 Billion; projected to reach USD 0.16 Billion by 2032.
    • CAGR of 6.30% during the forecast period (2024 - 2032).
    • Rising prevalence of chronic diseases, with 17.7 million deaths from cardiovascular diseases in 2015.
    • Launch of innovative products like Dispojekt single-use safety needle and concentric needles.

    Market Size & Forecast

    2023 Market Size USD 0.08 Billion
    2032 Market Size USD 0.16 Billion
    CAGR 6.30%

    Major Players

    Becton, Dickinson, and Company (US), B. Braun Melsungen AG (Germany), Ethicon Inc. (US), Teleflex Incorporated (US), Medline Industries, Inc. (US)

    Cardiovascular Needle Market Trends

    The ongoing advancements in cardiovascular needle technology appear to enhance procedural efficiency and patient outcomes, indicating a robust trajectory for market growth in the coming years.

    U.S. Food and Drug Administration (FDA)

    Cardiovascular Needle Market Drivers

    Market Growth Projections

    The Global Cardiovascular Needle Market Industry is projected to experience substantial growth in the coming years. With an anticipated market value of 0.09 USD Billion in 2024 and a potential increase to 0.19 USD Billion by 2035, the industry is set to expand significantly. The compound annual growth rate of 7.14% from 2025 to 2035 indicates a robust demand for cardiovascular needles, driven by factors such as technological advancements and increasing healthcare expenditure. This growth trajectory suggests a promising future for stakeholders in the cardiovascular needle market.

    Increasing Healthcare Expenditure

    Rising healthcare expenditure across various regions is a crucial factor propelling the Global Cardiovascular Needle Market Industry. Governments and private sectors are investing more in healthcare infrastructure, which includes the procurement of advanced medical devices. This trend is particularly evident in developing nations, where improving healthcare access and quality is a priority. Enhanced funding allows for the acquisition of innovative cardiovascular needles, thereby facilitating better treatment options for patients. As healthcare budgets expand, the market is likely to benefit from increased demand for high-quality medical devices.

    Regulatory Support for Medical Innovations

    Regulatory bodies worldwide are increasingly supportive of medical innovations, which positively impacts the Global Cardiovascular Needle Market Industry. Streamlined approval processes for new medical devices encourage manufacturers to invest in research and development. This regulatory environment fosters innovation, leading to the introduction of advanced cardiovascular needles that meet evolving clinical needs. For instance, expedited pathways for breakthrough devices enable quicker market entry for novel technologies. As a result, the market is expected to thrive, driven by a continuous influx of innovative products designed to enhance patient care.

    Rising Prevalence of Cardiovascular Diseases

    The increasing incidence of cardiovascular diseases globally is a primary driver for the Global Cardiovascular Needle Market Industry. As populations age and lifestyle-related health issues rise, the demand for effective cardiovascular interventions grows. For instance, the World Health Organization indicates that cardiovascular diseases account for a significant portion of global mortality. This trend necessitates advanced medical devices, including specialized needles for procedures such as angioplasty and catheterization. The market is projected to reach 0.09 USD Billion in 2024, reflecting the urgent need for innovative solutions in cardiovascular care.

    Technological Advancements in Medical Devices

    Technological innovations in medical devices are transforming the Global Cardiovascular Needle Market Industry. The introduction of smart needles, which enhance precision and reduce complications, is indicative of this trend. These advancements not only improve patient outcomes but also streamline procedures, making them more efficient. For example, the integration of imaging technologies with needles allows for better visualization during interventions. As a result, the market is expected to experience a compound annual growth rate of 7.14% from 2025 to 2035, potentially reaching 0.19 USD Billion by 2035, driven by continuous improvements in device technology.

    Growing Demand for Minimally Invasive Procedures

    The shift towards minimally invasive surgical techniques is significantly influencing the Global Cardiovascular Needle Market Industry. Patients and healthcare providers favor these procedures due to their associated benefits, such as reduced recovery times and lower risk of complications. Cardiovascular interventions, including stenting and catheterization, increasingly utilize specialized needles designed for such techniques. This trend is supported by clinical studies demonstrating improved patient outcomes with minimally invasive approaches. As the healthcare sector adapts to these preferences, the market is poised for growth, aligning with the projected increase in cardiovascular procedures.

    Market Segment Insights

    The global cardiovascular needle market is segmented on the basis of types, by application, by usage, and by the end user.

    Cardiovascular Needle Type Insights

    On the basis of the type, it is segmented into round bodied needles and cutting needles. Furthermore, round-bodied needles segmented into taper point needles and blunt point needles. Also, cutting needles segmented into conventional cutting needles and reverse cutting needles.  

    Cardiovascular Needle Market Application Insights

    On the basis of the application, it is segmented into open heart surgery, cardiac valve procedures, coronary artery bypass graft surgery, heart transplant, and others.  

    Cardiovascular Needle Usage Insights

    On the basis of the usage, it is segmented into single use and multiple uses.

    Cardiovascular Needle End User Insights

    On the basis of the end user, it is segmented into hospitals, clinics, ambulatory surgical centers, and others.

    Cardiovascular Needle Market Regional Analysis

    The Americas dominate the global cardiovascular needle market owing to the rising prevalence of diabetes, obesity, and cardiovascular diseases. Furthermore increasing government support for research & development have fuelled the growth of the market in this region. According to the American Heart Association, in 2017, cardiovascular disease listed as the underlying cause of death which is likely to account for nearly 801,000 deaths in the US by the end of this year. It further estimated that about 2,200 Americans die of cardiovascular disease each day.

    Europe holds the second position in the global market owing to the presence of major players. Although companies within this region are also involved in export to the developing countries which leads the market of Europe.

    The Asia Pacific is the fastest growing market owing to the high presence of a patient with cardiovascular disease. Furthermore, the government of this region is looking forward to better the quality of needles, which increases the demand for cardiovascular needle market in this region.

    On the other hand, in the Middle East and Africa hold the least market due to low research and development activities and poor healthcare infrastructure.

    Cardiovascular Needle Market Key Players

    Some of the key the players in the cardiovascular needles market are 

    • Becton, Dickinson, and Company (US), 
    • B. Braun Melsungen AG (Germany), 
    • Sheffield Ltd. (UK), 
    • CP Medical, Inc. (the US), 
    • Ethicon Inc. (US), 
    • KLS Martin Group (US), 
    • Sklar Surgical Instruments (US), 
    • Rumex International Corporation Ltd. (US), 
    • Scanlan International Inc. (US), 
    • Teleflex Incorporated (US), 
    • Medline Industries, Inc. (US), 
    • Surgins surgical Ltd. (UK), 
    • Surtex Instruments Ltd. (UK), 
    • Cardivon Surgical Inc. (China), 
    • Symmetry Surgical Inc. (US), 
    • Delacroix-Chevalier (France), 
    • Wexler Surgical (US), 
    • Quality Needles Pvt. Ltd. (India), 
    • FSSB surgical needles GmbH (Germany)

    Intended Audience

    • Cardiovascular needle manufacturers
    • Cardiovascular needle suppliers
    • Research and Development (R&D) Companies
    • Government Research Laboratories
    • Independent Research Laboratories
    • Government and Independent Regulatory Authorities
    • Market Research and Consulting Service Providers
    • Medical Research Laboratories
    • Academic Medical Institutes and Universities

    Regional Insights

    Key Companies in the Cardiovascular Needle Market market include

    Industry Developments

    Future Outlook

    Cardiovascular Needle Market Future Outlook

    The Global Cardiovascular Needle Market is projected to grow at a 7.14% CAGR from 2024 to 2035, driven by technological advancements, increasing cardiovascular diseases, and rising healthcare expenditures.

    New opportunities lie in:

    • Invest in R&D for innovative needle designs to enhance patient safety and comfort.
    • Expand distribution networks in emerging markets to capture untapped customer segments.
    • Leverage digital health technologies to integrate needle usage with telemedicine solutions.

    By 2035, the market is poised for robust growth, reflecting advancements and increased demand.

    Market Segmentation

    Report Scope

    Attribute/Metric Details
    Market Size 2023 0.08 (USD Billion)
    Market Size 2024 0.09 (USD Billion)
    Market Size 2032 0.16 (USD Billion)
    Compound Annual Growth Rate (CAGR) 6.3 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
      Geographies Covered North America, Europe, Asia-Pacific and Rest of the World (RoW)
      Key Vendors Becton, Dickinson, and Company (US), B. Braun Melsungen AG (Germany), Sheffield Ltd. (UK), CP Medical, Inc. (the US), Ethicon Inc. (US), KLS Martin Group (US), Sklar Surgical Instruments (US), Rumex International Corporation Ltd. (US), Scanlan International Inc. (US), Teleflex Incorporated (US), Medline Industries, Inc. (US), Surgins surgical Ltd. (UK), Surtex Instruments Ltd. (UK), Cardivon Surgical Inc. (China), Symmetry Surgical Inc. (US), Delacroix-Chevalier (France), Wexler Surgical (US), Quality Needles Pvt. Ltd. (India), FSSB surgical needles GmbH (Germany)
      Key Market Opportunities   Development activities
      Key Market Drivers Rising number of a patient having cardiovascular disease, Diabetes, obesity Increasing aging population

    Market Highlights

    Author
    Kinjoll Dey
    Research Analyst Level I

    He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

    Get In Touch
    Leave a Comment

    FAQs

    What would be the Cardiovascular Needle Market CAGR during the forecast period of 2022 to 2030?

    The CAGR would be 6.30% during the forecast period of 2024-2032.

    Who are the key players in the Cardiovascular Needle Market?

    Becton, Dickinson, and Company (US), B. Braun Melsungen AG (Germany), Sheffield Ltd. (UK), CP Medical, Inc. (the US), Ethicon Inc. (US), KLS Martin Group (US), Sklar Surgical Instruments (US), Rumex International Corporation Ltd. (US), Scanlan International Inc. (US), Teleflex Incorporated (US), Medline Industries, Inc. (US), Surgins surgical Ltd. (UK), Surtex Instruments Ltd. (UK), Cardivon Surgical Inc. (China), Symmetry Surgical Inc. (US), Delacroix-Chevalier (France), Wexler Surgical (US), Quality Needles Pvt. Ltd. (India), FSSB surgical needles GmbH (Germany) are the top key players in the market

    What are the end users included in the Cardiovascular Needle Market report?

    End users are ambulatory surgical centers, clinics, hospitals, and others.

    Which region would hold the maximum market share of the Cardiovascular Needle Market?

    The Americas would hold the maximum market share.

    What are the major applications included in the Cardiovascular Needle Market?

    The segments are cardiac valve procedures, open-heart surgery, heart transplant, coronary artery bypass graft surgery, and others.

    What would hinder the Cardiovascular Needle Market growth?

    The Cardiovascular Needle Market would get hindered by the increasing use of surgical staples.

    1. Report Prologue
    2. Market Introduction
      1.     Definition   
    3. Scope of the Study   
      1.     Research
    4. Objective   
      1.     Assumptions   
    5. Limitations   
    6. Research Methodology
    7. Introduction
      1.     Primary Research   
    8. Secondary research   
      1.     Market Size
    9. Estimation
    10. Market Dynamics
    11. Drivers    
      1.     Restrains
    12. Opportunities   
      1.     Challenges
    13. Macroeconomic Indicators
      1.     Technology Trends &
    14. Assessment           
    15. Market Factor Analysis
    16. Porter’s Five Forces Analysis
      1.     Bargaining
    17. Power of Suppliers   
      1.     Bargaining
    18. Power of Buyers
      1.     Threat of New Entrants   
    19. Threat of Substitutes   
      1.     Intensity
    20. of Rivalry   
      1.     Value Chain Analysis
    21. Investment Feasibility Analysis   
    22. Pricing Analysis
    23. Global Cardiovascular Needle Market,
    24. by Type
    25.      6.1    Introduction
    26. Round bodied needles
      1.     Market Estimates & Forecast,
      2.     Cutting needles
    27. Market Estimates & Forecast, 2020-2027
    28. Global
    29. Cardiovascular Needle Market, by Application
      1.     Introduction
      2.     Open Heart Surgery
    30. Market Estimates & Forecast, 2020-2027
      1.     Cardiac
    31. Valve Procedures
      1.     Market Estimates & Forecast,
      2.     Coronary Artery Bypass Graft Surgery
    32. Market Estimates & Forecast, 2020-2027
      1.     Heart
    33. Transplant
      1.     Market Estimates & Forecast, 2020-2027
    34. Others
      1.     Market Estimates & Forecast, 2020-2027
    35. Global Cardiovascular Needle Market, by Usage
      1.     Introduction
      2.     Single use
    36. Market Estimates & Forecast, 2020-2027
      1.     Multiple
    37. use
      1.     Market Estimates & Forecast, 2020-2027
    38. Global Cardiovascular Needle Market, by End User
    39. Introduction
      1.     Hospitals
    40. Market Estimates & Forecast, 2020-2027
      1.     Clinics
    41. Market Estimates & Forecast, 2020-2027
    42. Ambulatory Surgical Centers
      1.     Market Estimates & Forecast, 2020-2027
    43. Others
    44. Market Estimates & Forecast, 2020-2027
    45. Global
    46. Cardiovascular Needle Market, by Region
    47. Introduction
      1.     Americas
    48. North America
      1.     U.S.
    49. Canada
      1.     South America
    50. Europe
      1.     Western Europe
    51. Germany
      1.     France
    52. U.K
      1.     Italy
    53. Spain
      1.     Rest of Western Europe
    54. Eastern Europe
      1.     Asia Pacific
    55. Japan
      1.     China
    56. India
      1.     Australia
    57. Republic of Korea
      1.     Rest of Asia Pacific
    58. The Middle East & Africa
      1.     United Arab Emirates
    59. Saudi Arabia
      1.     Oman
    60. Kuwait
      1.     Qatar
    61. Rest of the Middle East & Africa
    62.     Company Landscape   
    63. Introduction   
      1.     Market Share Analysis   
    64. Key Development & Strategies   
    65. Key Developments   
    66.     Company Profiles   
    67. Becton, Dickinson and Company
      1.     Company Overview   
    68. Product Overview   
      1.     Financials   
    69. SWOT Analysis   
      1.     B. Braun Melsungen
    70. AG   
      1.     Company Overview   
    71. Product Overview   
      1.     Financial
    72. Overview   
      1.     Key Developments   
    73. SWOT Analysis   
      1.     Sheffield Ltd.
    74. Company Overview   
      1.     Product Overview   
    75. Financial Overview
      1.     Key Development   
    76. SWOT Analysis   
      1.      CP Medical,
    77. Inc.
      1.     Company Overview   
    78. Product/Business Segment Overview   
    79. Financial Overview   
      1.     Key Development   
    80. SWOT Analysis   
      1.     Ethicon Inc.
    81. Company Overview   
      1.     Product Overview   
    82. Financial overview   
      1.     Key Developments   
    83. KLS Martin Group
      1.     Company Overview   
    84. Product Overview   
      1.     Financial
    85. Overview   
      1.     Key Developments   
    86. Sklar Surgical Instruments
      1.     Overview   
    87. Product Overview   
      1.     Financials   
    88. Key Developments   
      1.     SWOT Analysis   
      2.     Rumex International Corporation Ltd.
    89. Overview   
      1.     Product Overview   
    90. Financials   
      1.     Key Developments   
    91. SWOT Analysis   
      1.     Others
    92. MRFR Conclusion   
      1.     Key Findings   
    93. From CEO’s View Point   
    94. Unmet Needs of the Market   
      1.     Key
    95. Companies to Watch   
      1.     Prediction
    96. of Pharmaceutical Industry
    97.     Appendix
    98. LIST
    99. OF TABLES
    100. Needle Industry Synopsis, 2020-2027
    101. Needle Market Estimates and Forecast, 2020-2027, (USD Million)
    102. Global Cardiovascular Needle Market by Region, 2020-2027, (USD Million)
    103.     Global Cardiovascular Needle Market by Types, 2020-2027, (USD
    104. Million)
    105. Needle Market by Application, 2020-2027, (USD Million)
    106. Global Cardiovascular Needle Market by Usage, 2020-2027, (USD Million)
    107.         Global Cardiovascular Needle Market
    108. by End Users, 2020-2027, (USD Million)
    109. America Cardiovascular Needle Market by Types, 2020-2027, (USD Million)
    110.     North America Cardiovascular Needle Market by Application, 2020-2027,
    111. (USD Million)
    112. Needle Market by Usage, 2020-2027, (USD Million)
    113. North America Cardiovascular Needle Market by End Users, 2020-2027, (USD Million)
    114.     US Cardiovascular Needle Market by Types, 2020-2027, (USD Million)
    115.     US Cardiovascular Needle Market by Application, 2020-2027,
    116. (USD Million)
    117. by Usage, 2020-2027, (USD Million)
    118. Needle Market by End Users, 2020-2027, (USD Million)
    119. Canada Cardiovascular Needle Market by Types, 2020-2027, (USD Million)
    120.     Canada Cardiovascular Needle Market by Application, 2020-2027,
    121. (USD Million)
    122. Market by Usage, 2020-2027, (USD Million)
    123. Cardiovascular Needle Market by End Users, 2020-2027, (USD Million)
    124.     South America Cardiovascular Needle Market by Types, 2020-2027,
    125. (USD Million)
    126. Needle Market by Application, 2020-2027, (USD Million)
    127. South America Cardiovascular Needle Market by Usage, 2020-2027, (USD Million)
    128.     South America Cardiovascular Needle Market by End Users, 2020-2027,
    129. (USD Million)
    130. Market by Types, 2020-2027, (USD Million)
    131. Cardiovascular Needle Market by Application, 2020-2027, (USD Million)
    132.     Europe Cardiovascular Needle Market by Usage, 2020-2027, (USD
    133. Million)
    134. by End Users, 2020-2027, (USD Million)
    135. Europe Cardiovascular Needle Market by Types, 2020-2027, (USD Million)
    136.     Western Europe Cardiovascular Needle Market by Application,
    137. 2027, (USD Million)
    138. Needle Market by Usage, 2020-2027, (USD Million)
    139. Western Europe Cardiovascular Needle Market by End Users, 2020-2027, (USD Million)
    140.     Eastern Europe Cardiovascular Needle Market by Types, 2020-2027,
    141. (USD Million)
    142. Needle Market by Application, 2020-2027, (USD Million)
    143. Eastern Europe Cardiovascular Needle Market by Usage, 2020-2027, (USD Million)
    144.     Eastern Europe Cardiovascular Needle Market by End Users, 2020-2027,
    145. (USD Million)
    146. Market by Types, 2020-2027, (USD Million)
    147. Pacific Cardiovascular Needle Market by Application, 2020-2027, (USD Million)
    148.     Asia Pacific Cardiovascular Needle Market by Usage, 2020-2027,
    149. (USD Million)
    150. Market by End Users, 2020-2027, (USD Million)
    151. Middle East & Africa Cardiovascular Needle Market by Types, 2020-2027, (USD
    152. Million)
    153. Needle Market by Application, 2020-2027, (USD Million)
    154. Middle East & Africa Cardiovascular Needle Market by Usage, 2020-2027, (USD
    155. Million)
    156. Needle Market by End Users, 2020-2027, (USD Million)
    157. LIST
    158. OF FIGURES
    159.     Segmentation for Global Cardiovascular Needle Market
    160.     Segmentation Market Dynamics for Cardiovascular Needle Market
    161.     Global Cardiovascular Needle Market Share, by Type 2020
    162.     Global Cardiovascular Needle Market Share, by Application 2020
    163.     Global Cardiovascular Needle Market Share, by Usage 2020
    164.     Global Cardiovascular Needle Market Share, by End Users, 2020
    165.     Global Cardiovascular Needle Market Share, by Region, 2020
    166.     America Cardiovascular Needle Market Share, by Country, 2020
    167.     Europe Cardiovascular Needle Market Share, by Country, 2020
    168.     Asia Pacific Cardiovascular Needle Market Share, by Country,
    169. Needle Market Share, by Country, 2020
    170. Cardiovascular Needle Market: Company Share Analysis, 2020 (%)
    171.     Becton, Dickinson and Company: Key Financials
    172.     Becton, Dickinson and Company: Segmental Revenue
    173.     Becton, Dickinson and Company: Geographical Revenue
    174.     B. Braun Melsungen AG: Key Financials
    175. B. Braun Melsungen AG: Segmental Revenue
    176. Braun Melsungen AG: Geographical Revenue
    177. Ltd.: Key Financials
    178. Revenue
    179.     CP Medical, Inc.: Key Financials
    180. CP Medical, Inc.: Segmental Revenue
    181. Inc.: Geographical Revenue
    182. Financials
    183.     Ethicon Inc.: Geographical Revenue
    184. KLS Martin Group: Key Financials
    185. Group: Segmental Revenue
    186. Geographical Revenue
    187. Key Financials
    188. Segmental Revenue
    189. Geographical Revenue
    190. Ltd.: Key Financials
    191. Ltd.: Segmental Revenue
    192. Corporation Ltd.: Geographical Revenue

    Cardiovascular Needle Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Cardiovascular Needle Market Research Report- Forecast till 2032 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027